A comparative study of surface hardness between two bioceramic materials

February 16, 2021

The placement of a wet cotton pellet against Mineral Trioxide Aggregate (MTA) is often recommended to ensure the completion of its setting reaction. This study aimed to evaluate the setting behaviour of MTA Angelus and NeoMTA by comparing their hardness after placing them in dry and moist conditions.

A simulated open apex was created on 40 polyvinyl tubes. The apical 4 mm of the tubes was filled with the two materials, NeoMTA Plus (Avalon Biomed Inc. Bradenton, FL, USA) and MTA Angelus (Angelus, Londrina, PR, Brazil) (n=20 per group). Both groups were subdivided into two subgroups based on the dry and wet conditions (n=10 per group). A wet cotton pellet was placed above the two materials in the wet group, and the coronal segment was sealed using Type II Glass ionomer cement (GC corporation Tokyo, Japan). Gutta-percha was placed against the test materials in the dry group with the coronal segment sealed with amalgam. Samples were placed in an oasis soaked in phosphate-buffered saline for seven days in 100% humidity and at 37°C.

Microhardness was measured independently at 4 and 2 mm from the apex. Hardness was compared between materials and conditions, applying analysis of variance (a = .05). The presence of dry or wet conditions had no significant effect on material hardness. MTA Angelus showed significantly higher hardness values compared with NeoMTA Plus. The moisture of the periapical environment can compensate for the absence of a wet cotton pellet and is adequate for the setting of the materials.
-end-
Read Full-text article here: https://benthamopen.com/ABSTRACT/TODENTJ-14-698

Bentham Science Publishers

Related Angelus Articles from Brightsurf:

A comparative study of surface hardness between two bioceramic materials
This study aimed to evaluate the setting behaviour of MTA Angelus and NeoMTA by comparing their hardness after placing them in dry and moist conditions.

Study in mice yields Angelman advance
In the journal PLOS Biology, a team of scientists reports experiments showing how the gene defect of Angelman syndrome disrupts neurological processes that may be needed for memory and learning.

New class of drugs may treat lung tumors resistant to Iressa and Tarceva
A new class of drugs that block the epidermal growth factor receptor (EGFR) on lung cancer cells may get around the growing problem of resistance to targeted therapy drugs like Iressa and Tarceva.

Gene mutations predict which lung cancers will respond to Iressa
Researchers from the Massachusetts General Hospital (MGH) Cancer Center have discovered a molecular marker that identifies lung cancer patients whose tumors will respond to treatment with the drug Iressa (gefitinib).

Read More: Angelus News and Angelus Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.